![Keith R. Walley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith R. Walley
Corporate Officer/Principal chez University of British Columbia
Postes actifs de Keith R. Walley
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of British Columbia | Corporate Officer/Principal | - | - |
Historique de carrière de Keith R. Walley
Anciens postes connus de Keith R. Walley
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cyon Therapeutics, Inc.
![]() Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada. | Fondateur | 01/05/2014 | 02/05/2014 |
Sirius Genomics, Inc.
![]() Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 01/01/2001 | - |
Fondateur | 01/01/2001 | - |
Formation de Keith R. Walley
University of Manitoba | Doctorate Degree |
Statistiques
Internationale
Canada | 5 |
Opérationnelle
Founder | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Sirius Genomics, Inc.
![]() Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Cyon Therapeutics, Inc.
![]() Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada. | Commercial Services |
- Bourse
- Insiders
- Keith R. Walley
- Expérience